Swedencare AB (publ) (SECARE.ST)

SEK 48.8

(-2.4%)

Total Assets Summary of Swedencare AB (publ)

Swedencare AB (publ)'s latest annual total assets in 2023 was 9.52 Billion SEK , down -4.82% from previous year.
Swedencare AB (publ)'s latest quarterly total assets in 2024 Q3 was 9.58 Billion SEK , down -4.51% from previous quarter.
Swedencare AB (publ) reported annual total assets of 10 Billion SEK in 2022, up 188.23% from previous year.
Swedencare AB (publ) reported annual total assets of 3.47 Billion SEK in 2021, up 201.71% from previous year.
Swedencare AB (publ) reported quarterly total assets of 9.58 Billion SEK for 2024 Q3, down -4.51% from previous quarter.
Swedencare AB (publ) reported quarterly total assets of 10.04 Billion SEK for 2024 Q2, down -0.82% from previous quarter.

Annual Total Assets Chart of Swedencare AB (publ) (2023 - 2013)

Historical Annual Total Assets of Swedencare AB (publ) (2023 - 2013)

Year	Total Assets	Total Assets Growth
2023	9.52 Billion SEK	-4.82%
2022	10 Billion SEK	188.23%
2021	3.47 Billion SEK	201.71%
2020	1.15 Billion SEK	669.82%
2019	149.44 Million SEK	26.79%
2018	117.86 Million SEK	24.51%
2017	94.66 Million SEK	2.05%
2016	92.76 Million SEK	137.23%
2015	39.1 Million SEK	238.64%
2014	11.54 Million SEK	19.25%
2013	9.68 Million SEK	0.0%

Year	Total Assets	Total Assets Growth
2024 Q1	10.12 Billion SEK	6.32%
2024 Q3	9.58 Billion SEK	-4.51%
2024 Q2	10.04 Billion SEK	-0.82%
2023 Q1	9.89 Billion SEK	-1.12%
2023 Q4	9.52 Billion SEK	-6.9%
2023 FY	9.52 Billion SEK	-4.82%
2023 Q3	10.22 Billion SEK	-0.94%
2023 Q2	10.32 Billion SEK	4.37%
2022 Q1	9.26 Billion SEK	166.97%
2022 Q3	10.88 Billion SEK	6.66%
2022 FY	10 Billion SEK	188.23%
2022 Q2	10.2 Billion SEK	10.14%
2022 Q4	10 Billion SEK	-8.09%
2021 Q4	3.47 Billion SEK	9.48%
2021 FY	3.47 Billion SEK	201.71%
2021 Q3	3.17 Billion SEK	21.97%
2021 Q2	2.59 Billion SEK	100.06%
2021 Q1	1.29 Billion SEK	12.93%
2020 Q3	706.91 Million SEK	147.4%
2020 FY	1.15 Billion SEK	669.82%
2020 Q2	285.74 Million SEK	77.85%
2020 Q1	160.66 Million SEK	7.51%
2020 Q4	1.15 Billion SEK	62.75%
2019 Q3	144.83 Million SEK	4.98%
2019 Q2	137.95 Million SEK	3.73%
2019 FY	149.44 Million SEK	26.79%
2019 Q1	133 Million SEK	12.84%
2019 Q4	149.44 Million SEK	3.19%
2018 Q4	117.86 Million SEK	2.12%
2018 FY	117.86 Million SEK	24.51%
2018 Q3	115.42 Million SEK	3.31%
2018 Q2	111.72 Million SEK	5.95%
2018 Q1	105.44 Million SEK	11.39%
2017 FY	94.66 Million SEK	2.05%
2017 Q2	92.35 Million SEK	-2.83%
2017 Q3	94.81 Million SEK	2.67%
2017 Q4	94.66 Million SEK	-0.16%
2017 Q1	95.04 Million SEK	2.46%
2016 Q1	33.31 Million SEK	-14.81%
2016 Q4	92.76 Million SEK	33.78%
2016 Q3	69.34 Million SEK	12.0%
2016 Q2	61.91 Million SEK	85.85%
2016 FY	92.76 Million SEK	137.23%
2015 FY	39.1 Million SEK	238.64%
2015 Q4	39.1 Million SEK	0.0%
2015 Q1	- SEK	0.0%
2014 FY	11.54 Million SEK	19.25%
2013 FY	9.68 Million SEK	0.0%

Peer Total Assets Comparison of Swedencare AB (publ)

Name	Total Assets	Total Assets Difference
AcuCort AB	58.5 Million SEK	-16175.147%
AlzeCure Pharma AB (publ)	32 Million SEK	-29655.634%
BioGaia AB (publ)	2.33 Billion SEK	-308.115%
Enzymatica AB (publ)	125.91 Million SEK	-7462.564%
Enorama Pharma AB (publ)	34.38 Million SEK	-27592.599%
Gabather AB (publ)	2.93 Million SEK	-324111.781%
Klaria Pharma Holding AB (publ.)	73.12 Million SEK	-12922.566%
Moberg Pharma AB (publ)	634.73 Million SEK	-1400.176%
Nanexa AB (publ)	132.25 Million SEK	-7099.695%
Newbury Pharmaceuticals AB (publ)	90.87 Million SEK	-10378.701%
ODI Pharma AB	12.27 Million SEK	-77473.154%
Orexo AB (publ)	786.6 Million SEK	-1110.539%
Probi AB (publ)	1.55 Billion SEK	-514.171%
Swedish Orphan Biovitrum AB (publ)	74.02 Billion SEK	87.137%
Toleranzia AB	160.42 Million SEK	-5835.472%
Vivesto AB	355.87 Million SEK	-2575.679%